Xi Jinping touches down in Washington on September 24 for round two with Trump, and this time there’s a scorecard everyone’s checking. I walk through three threads converging on that meeting, chip export controls, the wobbly May Boeing order, and a Taiwan arms sale that nearly got the summit cancelled outright. None of this is about a photo opportunity in Washington, it’s about knowing exactly which SGX names sit closest to each thread before Thursday, not after.
Key takeaways:
Chip export controls remain the least resolved thread of the year, and AEM Holdings and UMS Holdings sit inside the equipment supply chain that feels any shift first.
The May Boeing order for two hundred jets has reportedly been shaky for months over engine part conditions, and whether it closes now hinges on this summit.
ST Engineering sits adjacent to the Boeing story through its aerospace MRO business, a slower and more indirect read than the chip names.
A pending Taiwan arms sale was floated as a reason to cancel the summit entirely, a risk to the whole room’s tone, not just one agenda item.
Nothing to do differently before Thursday, the point is knowing your exposure, not predicting which way it breaks.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
